PT  - JOURNAL ARTICLE
ED - BMJ Publishing Group Ltd
TI  - ▾ Ondansetron to prevent chemotherapy-induced vomiting
AID  - 10.1136/dtb.30.6.21
DP  - 1992 Mar 16
TA  - Drug and Therapeutics Bulletin
PG  - 21--23
VI  - 30
IP  - 6
4099  - http://dtb.bmj.com/content/30/6/21.short
4100  - http://dtb.bmj.com/content/30/6/21.full
SO  - Drug Ther Bull1992 Mar 16; 30
AB  - Nausea and vomiting are very common within a few hours of administration of cytotoxic drugs, and may be severe enough to interrupt treatment or interfere with nutrition. The resulting dehydration may exacerbate toxic effects of the drugs. Ondansetron (Zofran – Glaxo) is an important new type of drug for the prevention of vomiting and nausea induced by chemotherapy and radiotherapy.